|
IL-8 Antibody, mAb, Mouse  |
|
|
| Full Name |
IL-8 Antibody, mAb, Mouse
|
Abbreviated name-1 |
human IL-8; human Interleukin-8; Interleukin-8; Neutrophil activating protein-1 |
| Documents |
Document-MSDS: 995_20051003104713.PDF (PDF) |
Document-MSDS: NaN3 MSDS.pdf (pdf) |
| Figures |
zoom |
| Reference |
Kurdowska AK, et al. Interleukin-8 and anti-interleukin-8 autoantibodies in gingival crevicular fluid from patients with periodontitis. J. Periodontal. Res. Feb 2003; 38(1): 73-78.
Mian BM, et al. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin. Cancer Res. Aug 2003; 9(8): 3167-3175.
|
|
Description |
IL-8, also known as neutrophil chemotactic factor, neutrophil activating protein, and monocyte-derived neutrophil chemotactic factor, is a member of the alpha (C-X-C) subfamily of chemokines called CXCL8. In response to proinflammatory stimuli, IL-8 is produced by monocytes, macrophages, T cells, neutrophils, and fibroblasts. IL-8 promotes neutrophil chemotaxis and degranulation. The 72-amino acid IL-8 is the predominant form secreted by monocytes and lymphocytes. Recombinant human IL-8 is an 8,400 Da protein containing 72 amino acids. This antibody reacts with human Interleukin-8 (IL-8) protein. The immunogen used to produce the antibody is recombinant human IL-8 produced in E. coli containing 72 amino acids and having a molecular mass of 8,452 Da. |
Ig Subclass |
Mouse IgG1 |
Storage |
The antibody is stable for 2-3 weeks if stored at 2-8°C. For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles. |
Specificity |
Human,Reactivity to other species is not tested yet. |
Concentration |
1 mg/ml in PBS, pH 7.4 with 0.02% sodium azide |
Immunogen |
Purified recombinant human IL-8 |
Purification Method |
Protein G affinity column |
Applications |
Working concentrations for specific applications should be determined by the investigator. Appropriate concentrations will be affected by several
factors, including secondary antibody affinity, antigen concentration,
sensitivity of detection method, temperature, and length of incubations,
etc. The suitability of this antibody for applications other than those
listed below has not been determined. The following concentration ranges
are recommended starting points for this product. ELISA: 0.1-1 µg/ml Western blot: 1 µg/ml |
Fusion Partner |
Spleen cells are fused with SP2/0-Ag14 mose myeloma cells. |
Conjugation |
Unconjugated |
Host Species |
Mouse |
Antigen Species |
Human |
Note |
This antibody is produced in BALB/c mice. |
Technical Manual |
ELISA Protocol (pdf) Western Blot Protocol (pdf) FACS Protocol (pdf) IHC Protocol (pdf) IP Protocol (pdf)
|
 |
1 |
Antibody Services: GenScript's custom antibody service guarantees 1:32,000 ELISA titer of final product or two ELISA positive clones with the help of our advanced antigen design tool. |
2 |
Polyclonal
antibody Services: GenScript's custom polyclonal antibody
services start from $250. It comes with a 1:32,000 ELISA titer guarantee, thanks to our advanced
antigen design tool. |
3 |
Custom
Monoclonal Antibody Services: GenScript's custom monoclonal antibody service
guarantees two ELISA positive clones with the help of advanced hybridoma technology & experienced
professional. |
|